Suboxone (buprenorphine and naloxone) is meant to treat opioid use disorder, but it causes patients serious teeth and gum injuries that require painful and expensive dental work.
Shouse Law Group is suing Indivior, the maker of Suboxone, in pursuit of the largest financial settlement possible for Suboxone victims. We are accepting clients across the United States who:
- have been prescribed Suboxone (as a sublingual film) for opioid addiction or pain management; and
- used prescription Suboxone for at least six months before suffering injuries; and
- have one or more of the following injuries: Cavities, tooth loss, tooth fractures, tooth decay, oral surgeries, tongue injuries and gum injuries; and
- have had routine dental care prior to Suboxone usage; and
- have no reported use of methamphetamine and/or convictions related to methamphetamine prior to diagnosis.
In this article, our Suboxone attorneys answer these frequently asked questions:
- Indivior to pay $30 million to settle health plans’ Suboxone claims, Reuters (October 21, 2023).
- Indivior, Inc. to Pay $10 Million to Consumers, Settling FTC Charges that the Company Illegally Maintained a Monopoly over the Opioid Addiction Treatment Suboxone, FTC (July 24, 2020).
- Indivior Solutions Pleads Guilty To Felony Charge And Indivior Entities Agree To Pay $600 Million To Resolve Criminal And Civil Investigations As Part Of DOJ’s Largest Opioid Resolution, U.S. Department of Labor (July 24, 2020).
- Erik Larson, Drug Distributor Reckitt to Pay $700 Million Over Opioid Marketing, Bloomberg (October 23, 2019).
- See Medications for Opioid Use Disorder Study (MOUD Study), Centers for Disease Control (CDC). Narcotic analgesic combinations, Drugs.com (April 14, 2023).